Innovent Biologics Inc. (IVBXF)
OTC: IVBXF
· Real-Time Price · USD
12.72
0.34 (2.75%)
At close: Oct 03, 2025, 1:56 PM
Innovent Biologics Cash Flow Statement
Financials in CNY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | 1.13B | -94.63M | -1.28B | -1.03B | -1.37B | -2.18B | -2.68B | -2.73B | -1.39B |
Depreciation & Amortization | 265.99M | 198.67M | 381.81M | 370.77M | 339.48M | 276.79M | 237.6M | 202.17M | 118.7M |
Stock-Based Compensation | 601.18M | 556.52M | 644.93M | 574.2M | 435.31M | 469.49M | 523.71M | 501.57M | 486.88M |
Other Working Capital | 200.82M | 447.7M | 550.61M | 566.77M | -411.58M | -313.45M | 858.87M | 864.46M | 444.09M |
Other Non-Cash Items | 341.29M | 176.65M | 100.82M | -264.33M | -1.06B | -460.11M | -185.08M | 272.01M | 985.89M |
Deferred Income Tax | n/a | n/a | n/a | 96.89M | -761.46M | -757.24M | 101.11M | 822.5M | 882.35M |
Change in Working Capital | -524.35M | 449.82M | 708.89M | 495.09M | -85.42M | -25.7M | 283.34M | -271.84M | -777.21M |
Operating Cash Flow | 1.82B | 1.29B | 555.07M | 147.81M | -1.73B | -1.92B | -1.82B | -2.02B | -579.52M |
Capital Expenditures | -368.73M | -965.66M | -1.22B | -1.12B | -1.07B | -896.9M | -1.15B | -1.07B | -803.22M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 35.64M | -465.9M | -1.06B | 120.72M | -23.75M | -538.29M | -955.41M | -1.63B | -3.65B |
Investing Cash Flow | -66.93M | -1.17B | -2.28B | -998.66M | -1.09B | -1.44B | -2.1B | -2.7B | -4.45B |
Debt Repayment | 547.98M | -330.13M | -330.13M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -245.38M | -276.5M | 2.41B | 2.59B | 2.91B | 2.89B | 723.44M | 5B | 7.23B |
Financial Cash Flow | 302.6M | -606.63M | 2.08B | 2.59B | 2.91B | 2.89B | 723.44M | 5B | 7.23B |
Net Cash Flow | 2.06B | -2.23B | 190.85M | 864.76M | -9.89M | -171.62M | -1.56B | -539.5M | 166.96M |
Free Cash Flow | 1.45B | 321.36M | -665.93M | -971.58M | -2.8B | -2.82B | -2.96B | -3.09B | -1.38B |